Consolidated Statements of Cash Flows - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (2,282,026)	$ 5,548,275
Adjustments to reconcile net income (loss) to net cash used in operating activities:
General and administrative expenses paid by Sponsor under promissory note	959
Change in fair value of derivative warrant liabilities	1,673,870	(7,977,860)
Financing costs - derivative warrant liabilities	469,004
Income on investments held in Trust Account	(11,212)	(110,381)
Changes in operating assets and liabilities:
Prepaid expenses	(316,989)	224,516
Accounts payable	332,263	(200,410)
Due to related party		30,811
Accrued expenses		1,528,232
Franchise tax payable	106,899	53,198
Net cash used in operating activities	(27,232)	(903,619)
Cash Flows from Investing Activities
Investment income released from Trust Account		78,517
Cash deposited in Trust Account	(172,500,000)
Net cash provided by (used in) investing activities	(172,500,000)	78,517
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from note payable to related party	30,000
Repayment of note payable to related party	(30,959)
Proceeds received from initial public offering, gross	172,500,000
Proceeds received from private placement	4,850,000
Offering costs paid	(3,905,567)
Net cash provided by financing activities	173,468,474
Net change in cash and cash equivalent	941,242	(825,102)
Cash and cash equivalent - beginning of the period		941,242
Cash and cash equivalent - end of the period	941,242	116,140
Supplemental disclosure of noncash financing activities:
Offering costs included in accrued expenses	70,000
Deferred underwriting commissions in connection with the initial public offering	$ 6,037,500